Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01929902
Other study ID # 07-13-04E
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2013
Est. completion date March 2014

Study information

Verified date April 2014
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to test the efficacy and accuracy of the Aquamantys device.


Description:

The primary objective of this study is to assess the efficacy of placement and accuracy of the Aquamantys device in 20 patients that require general surgery. High frequency electrosurgery is the application of frequency in the range of 300 kHz up to several MHz in order to coagulate or destroy tissue. Due to technological advancements, knowledge of how frequency and other physical modes interact with biological materials has become increasingly important in order for the surgeon to provide a safe and consistent surgery. The Aquamantys system utilizes radiofrequency energy and saline irrigation for cutting tissue and stopping excessive bleeding. The Aquamantys system features the following: 1. Cone-shaped electrodes designed to aid blunt dissection; 2. Large bipolar electrode configuration allowing for hemostatic sealing across broad planes of tissue; 3. Bipolar electrodes alleviate the need for grounding pad; 4. Transcollation technology allows for controlled depth of energy penetration. During surgery, the Aquamantys device will be utilized in order to stop excessive bleeding and to cut vessels. The patient will be monitored by the surgeon and research nurse coordinator before surgery, intra-operatively and post-operatively until discharge from the hospital. The study participant will follow-up post-operatively with the surgeon per standard of care.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date March 2014
Est. primary completion date January 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Indication for general surgery to include: liver resection and pancreatectomy - Male or females age 18 years of age or older Exclusion Criteria: - Indication for emergency surgery - Suspected inability, e.g. language problems or the inability to comply with trial procedures - Employee at the investigational center, Sponsor or Sponsor's representative, relative or spouse of the investigator - Females who are pregnant or breastfeeding

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Carolinas Healthcare System Charlotte North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Wake Forest University Health Sciences Medtronic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of the Aquamantys Device Efficacy of device will be measured based on intra-operative and post-operative complication variables: estimated blood loss, blood transfusion, complications intra-operative and post-operative. 1 year
Primary Placement of Aquamantys Device Evaluation of device placement will be measured based on vessel sealing variables: number of applications, vessel site, type of tissue to be sealed, number of failed and successful seals, tissue sticking, tissue color, thermal spread and desiccation. 1 year
Secondary Device Complications Functional evaluation of device based on the variable: device malfunction. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06208579 - Feasibility and Effectiveness of Augmented Reality Assistance System for Pancreatic Surgery
Completed NCT00414908 - A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy Phase 3
Completed NCT00559364 - Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea Phase 3
Active, not recruiting NCT04431076 - Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
Recruiting NCT05297136 - Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy N/A
Completed NCT03060408 - Comparison of Fluid Requirements in Pancreatectomy: Laparotomy vs. Laparoscopy N/A
Recruiting NCT02230436 - Early Versus Late Drain Removal After Pancreatectomy: A Randomized Prospective Trial N/A
Completed NCT02509910 - Implementation of a GDT Algorithm for Major Surgery Patients N/A
Terminated NCT02617979 - Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement N/A
Recruiting NCT06126601 - Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Completed NCT02623803 - Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies Phase 4
Terminated NCT02649023 - Deep Venous Thrombosis After Hepatobiliopancreatic Surgery
Completed NCT02814812 - Postoperative Comput Tomography as a Predictor of Postoperative Complications After Pancreatic Surgery N/A
Completed NCT06424431 - Methods of Pancreatic Stump Closure for Distal Pancreatectomy N/A
Active, not recruiting NCT04423731 - Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
Recruiting NCT05856474 - Management of Traumatic Pancreas Transection
Not yet recruiting NCT05992857 - Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty N/A
Completed NCT01950845 - Automated Versus Manual Fluid Management for High Risk Abdominal Surgical Patient. A Prospective, Randomized Trial N/A
Not yet recruiting NCT04850430 - Gastric Venous Reconstruction After Total Pancreatectomy N/A
Not yet recruiting NCT05722548 - Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis Phase 2